Navigation Links
Isis Pharmaceuticals to Present at Thomas Weisel Partners' Healthcare Conference 2009
Date:9/3/2009

CARLSBAD, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2009 Thomas Weisel Partners Healthcare Conference on Wednesday, September 9, 2009, at 11:30 a.m. ET at the Boston Four Seasons Hotel.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism
2. DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
3. Transdel Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
4. MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
5. Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
6. EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction
7. Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
8. Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009
9. Keryx Biopharmaceuticals, Inc. To Present at the Rodman & Renshaw Annual Global Investment Conference and To Hold Investor/Analyst Day
10. Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs
11. Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 ... launch of two new product extensions, an accompanying ... headquarters, several novel marketing tools for their sales ... Vitamin Angels at their 5th annual national convention, ... room only crowd at the Hyatt Regency Orange ...
(Date:9/16/2014)... Recently, iFitDress.com, one of the most famous dress suppliers ... evening gown collection. According to the company’s sales manager, ... (up to 69% off) at present. Additionally, all the company’s ... am a frequent caller of your site. I like your ... feel quite happy. All items are of good quality. I ...
(Date:9/16/2014)... 2014 Today, Top10BestSEOHosting.com compares ... the USA and announces that HostMonster, Arvixe ... best Windows web hosting companies in the ... clients high quality WordPress hosting (including VPS ... , HostMonster provides outstanding customer support and ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Paradigm Physical ... offering a new therapeutic treatment for their patients. Dry ... to treat a variety of musculoskeletal problems. , In ... is inserted into the skin and muscle to create ... the needle, the needle helps to deactivate and release ...
(Date:9/16/2014)... September 16, 2014 Cliff Lake Dental Care ... Kristaleen is the newest dental hygienist to join Dr. Rauchwarter's ... to working with her and knows she will bring many ... , Kristaleen grew up in River Falls, WI. She ... College in 2003 and practiced dental assisting in the Twin ...
Breaking Medicine News(10 mins):Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:iFitDress.com: One Shoulder Evening Gown Collection Unveiled Online 2Health News:Best Windows Web Hosting Suppliers Recommended By SEO Hosting Review Site Top10BestSEOHosting.com 2Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2
... Data Shows a Comprehensive Technology Infrastructure Improves Efficiency, ... March 10 Two Kaiser Permanente studies published ... a comprehensive electronic health record can increase consumer ... clinical quality and that connecting patients directly with ...
... More physician leaders are embracing technological advances, such as ... and unresponsive to their needs.Those are the results found ... Physician Executives (ACPE). The findings were published in the ... of medical management.ACPE conducted the same survey back in ...
... N.Y., March 10 NBTY, Inc. (NYSE: ... and marketer of nutritional supplements, today announced that it ... Chief Financial Officer of NBTY, at the B. Riley ... Wednesday, March 18, 2009.The presentation is scheduled to be ...
... Adjusted FIFO EBITDA Increases 4.3% to $26.1 Million, Excluding ... Full Year Adjusted FIFO EBITDA Increases 15% to $90.5 ... Net Cash Provided by Operating Activities Increases 130% to ... Million and Full Year Net Loss of $72.8 Million ...
... in corrective surgery operations from 2007 and 2008. ... is breast augmentations (breast enlargements), tummy tucks and ... largest cosmetic surgeons in the UK, can reveal ... cosmetic procedures, with the figure worryingly increasing to ...
... Holdings Ltd,("Obio"/ "the Company") announced the discovery of a ... influenza virus (including avian and human,influenza strains) such as ... TG21 has already commenced. , ... in USA and,China to conduct various researches, all of ...
Cached Medicine News:Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 2Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 3Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 4Health News:Survey Results: Health Care Technology Advances as Physician Frustration Grows 2Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 2Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 3Health News:NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009 4Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 2Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 3Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 4Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 5Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 6Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 7Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 8Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 9Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 10Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 11Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 12Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 13Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 14Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 15Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 16Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 17Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 18Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 19Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 20Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 21Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 22Health News:Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results 23Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 2Health News:Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3
(Date:9/16/2014)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ... acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. ... of $28.10 in a cash and stock transaction valued at ... 31% to Auxilium,s closing price on September 16, 2014 and ... shares for the previous 30 days.  Under the terms of ...
(Date:9/16/2014)... YORK , Sept. 16, 2014  This report analyzes ... Units, The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... , and Rest of World. Annual estimates and forecasts ... seven-year historic analysis is provided for these markets. Market data ...
(Date:9/16/2014)... , Sept. 16, 2014 Adaptive Biotechnologies, a ... (NGS) to profile the adaptive immune system, is pleased ... as Chief Commercial Officer (CCO). The addition of Brain ... key hires from leading global healthcare companies, including ... (General Counsel) from Genomic Health and Sean Nolan ...
Breaking Medicine Technology:Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8Global Digital Radiography Industry 9Global Digital Radiography Industry 10Global Digital Radiography Industry 11Global Digital Radiography Industry 12Global Digital Radiography Industry 13Global Digital Radiography Industry 14Global Digital Radiography Industry 15Global Digital Radiography Industry 16Global Digital Radiography Industry 17Global Digital Radiography Industry 18Global Digital Radiography Industry 19Global Digital Radiography Industry 20Global Digital Radiography Industry 21Global Digital Radiography Industry 22Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3
... intended for the immunochromatographic, qualitative determination ... Strip Gonorrhea is based on the ... determination of gonorrhea antigen in the ... system as an aid in the ...
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
The Smart Check Syphilis Device is a qualitative membrane device based immunoassay for the detection of TP (Treponema Pallidum) antibodies in whole blood/serum/plasma. For professional in vitro diagn...
Bio-Quant, Inc. OneStep hCG InstaTest is an immunochromatographic assay designed for qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy....
Medicine Products: